Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H23NO |
Molecular Weight | 233.3492 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)C[C@@H]1CCCC[C@H]1C2=CC(O)=CC=C2
InChI
InChIKey=JIRYWFYYBBRJAN-ZFWWWQNUSA-N
InChI=1S/C15H23NO/c1-16(2)11-13-6-3-4-9-15(13)12-7-5-8-14(17)10-12/h5,7-8,10,13,15,17H,3-4,6,9,11H2,1-2H3/t13-,15-/m0/s1
Molecular Formula | C15H23NO |
Molecular Weight | 233.3492 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22337471
During 4-week treatment periods, daily oral doses of faxeladol (GRT9906) 120-240 mg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:52:18 GMT 2023
by
admin
on
Sat Dec 16 16:52:18 GMT 2023
|
Record UNII |
C04V6SGK8H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20912318
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
C80579
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
300000034224
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
UU-170
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
9813414
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
C04V6SGK8H
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
433265-65-7
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
8787
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
FAXELADOL
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103829
Created by
admin on Sat Dec 16 16:52:18 GMT 2023 , Edited by admin on Sat Dec 16 16:52:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|